Photobiomodulation: lasers vs. light emitting diodes? V Heiskanen, MR Hamblin Photochemical & Photobiological Sciences 17 (8), 1003-1017, 2018 | 395 | 2018 |
Under the spotlight: mechanisms of photobiomodulation concentrating on blue and green light H Serrage, V Heiskanen, WM Palin, PR Cooper, MR Milward, M Hadis, ... Photochemical & Photobiological Sciences 18 (8), 1877-1909, 2019 | 159 | 2019 |
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022 J Robijns, RG Nair, J Lodewijckx, P Arany, A Barasch, JM Bjordal, P Bossi, ... Frontiers in oncology 12, 927685, 2022 | 90 | 2022 |
Non‐mammalian hosts and photobiomodulation: do all life‐forms respond to light? MR Hamblin, YY Huang, V Heiskanen Photochemistry and photobiology 95 (1), 126-139, 2019 | 56 | 2019 |
Photobiomodulation therapy for cancer treatment-related salivary gland dysfunction: a systematic review V Heiskanen, Y Zadik, S Elad Photobiomodulation, photomedicine, and laser surgery 38 (6), 340-347, 2020 | 35 | 2020 |
Sunlight and health: Shifting the focus from vitamin D3 to photobiomodulation by red and near-infrared light V Heiskanen, M Pfiffner, T Partonen Ageing research reviews 61, 101089, 2020 | 29 | 2020 |
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022. Front Oncol 12: 927685 J Robijns, RG Nair, J Lodewijckx, P Arany, A Barasch, JM Bjordal, P Bossi, ... | 8 | 2022 |
Nicotinamide riboside alleviates Parkinson’s disease symptoms but downregulates dopamine metabolism upon lactacystin-induced proteostasis failure G Turconi, F Alam, T SenGupta, S Pirnes-Karhu, S Olfat, MS Schmidt, ... bioRxiv, 2021.03. 12.435062, 2021 | 2 | 2021 |
Mitokondrioiden toimintahäiriö aineenvaihduntasairauksissa - tulevatko B3-vitamiinit aikanaan avuksi? V Heiskanen, E Pirinen Duodecim 136 (9), 1005-12, 2020 | 1 | 2020 |
Seerumin lipopolysakkaridiaktiivisuus ja parodontiittibakteerien vasta-aineet sydäninfarktissa: tapaus-verrokkitutkimus V Heiskanen | 1 | 2016 |
Punainen valo ja lähi-infrapuna sairaustilojen hoidossa V Heiskanen, T Partonen Erikoislääkäri, 2016 | 1 | 2016 |
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease G Turconi, F Alam, T SenGupta, S Pirnes-Karhu, S Olfat, MS Schmidt, ... Heliyon 10 (14), 2024 | | 2024 |
Nicotinamide riboside alleviates Parkinson's disease symptoms but downregulates dopamine metabolism G Turconi, F Alam, T SenGupta, S Pirnes-Karhu, S Olfat, M Schmidt, ... Parkinsonism & Related Disorders 113, 2023 | | 2023 |